See more : Laurentian Bank of Canada (LAUCF) Income Statement Analysis – Financial Results
Complete financial analysis of USANA Health Sciences, Inc. (USNA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of USANA Health Sciences, Inc., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
You may be interested
- Jiangsu Teeyer Intelligent Equipment Co.,Ltd. (603273.SS) Income Statement Analysis – Financial Results
- Gladstone Capital Corporation (GLAD) Income Statement Analysis – Financial Results
- ASNOVA CO LTD (9223.T) Income Statement Analysis – Financial Results
- Braxia Scientific Corp. (BRAXF) Income Statement Analysis – Financial Results
- Jinlei Technology Co., Ltd. (300443.SZ) Income Statement Analysis – Financial Results
USANA Health Sciences, Inc. (USNA)
About USANA Health Sciences, Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 921.01M | 998.60M | 1.19B | 1.13B | 1.06B | 1.19B | 1.05B | 1.01B | 918.50M | 790.47M | 718.18M | 648.73M | 581.94M | 517.64M | 436.94M | 429.01M | 423.15M | 374.19M | 327.74M | 272.82M | 200.01M | 133.78M | 114.28M | 123.18M | 129.40M | 121.60M | 85.20M | 56.70M | 24.50M | 7.30M |
| Cost of Revenue | 176.69M | 193.89M | 217.90M | 209.11M | 187.50M | 200.71M | 179.40M | 180.19M | 159.68M | 140.79M | 127.44M | 115.80M | 101.69M | 95.48M | 89.80M | 88.88M | 87.89M | 89.55M | 78.02M | 66.82M | 44.42M | 33.39M | 32.80M | 32.16M | 21.00M | 21.90M | 15.60M | 10.80M | 5.40M | 0.00 |
| Gross Profit | 744.32M | 804.71M | 968.57M | 925.53M | 873.40M | 988.54M | 867.86M | 825.89M | 758.82M | 649.68M | 590.74M | 532.92M | 480.25M | 422.16M | 347.14M | 340.13M | 335.26M | 284.65M | 249.73M | 206.00M | 155.59M | 100.38M | 81.48M | 91.02M | 108.40M | 99.70M | 69.60M | 45.90M | 19.10M | 7.30M |
| Gross Profit Ratio | 80.82% | 80.58% | 81.63% | 81.57% | 82.33% | 83.12% | 82.87% | 82.09% | 82.61% | 82.19% | 82.26% | 82.15% | 82.53% | 81.55% | 79.45% | 79.28% | 79.23% | 76.07% | 76.20% | 75.51% | 77.79% | 75.04% | 71.30% | 73.89% | 83.77% | 81.99% | 81.69% | 80.95% | 77.96% | 100.00% |
| Research & Development | 11.45M | 11.56M | 11.11M | 10.63M | 10.26M | 10.24M | 8.95M | 8.84M | 6.42M | 5.13M | 5.08M | 4.66M | 0.00 | 0.00 | 0.00 | 0.00 | 3.36M | 3.20M | 2.34M | 2.03M | 1.38M | 1.04M | 1.08M | 1.41M | 1.40M | 1.40M | 1.20M | 800.00K | 300.00K | 0.00 |
| General & Administrative | 256.99M | 262.30M | 279.11M | 261.19M | 267.73M | 275.06M | 265.09M | 234.19M | 209.00M | 184.53M | 166.21M | 154.24M | 402.99M | 353.95M | 296.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 434.79M | 519.27M | 487.86M | 459.48M | 525.13M | 470.26M | 453.08M | 408.16M | 349.04M | 307.82M | 280.51M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 256.99M | 697.10M | 798.37M | 749.04M | 727.21M | 800.19M | 735.36M | 687.27M | 617.16M | 533.58M | 474.03M | 434.74M | 402.99M | 353.95M | 296.35M | 292.14M | 261.19M | 219.11M | 189.02M | 159.13M | 123.09M | 86.56M | 76.20M | 79.97M | 88.50M | 79.70M | 55.60M | 36.40M | 15.00M | 0.00 |
| Other Expenses | 382.81M | 1.01M | 450.00K | 1.46M | 4.31M | 3.16M | 2.14M | -70.00K | 927.00K | -449.00K | -131.00K | 247.00K | 164.24M | 137.71M | 106.56M | 89.43M | 82.49M | 56.71M | 50.68M | 37.61M | 34.25M | 17.78M | 11.11M | 4.19M | 4.50M | 3.40M | 2.20M | 800.00K | 300.00K | 0.00 |
| Operating Expenses | 651.25M | 697.10M | 798.37M | 749.04M | 727.21M | 800.19M | 735.36M | 687.27M | 617.16M | 533.58M | 474.03M | 434.74M | 402.99M | 353.95M | 296.35M | 292.14M | 264.56M | 222.30M | 191.36M | 161.16M | 124.47M | 87.59M | 77.28M | 85.57M | 94.40M | 84.50M | 59.00M | 38.00M | 15.60M | 0.00 |
| Cost & Expenses | 827.94M | 890.99M | 1.02B | 958.15M | 914.71M | 1.00B | 914.76M | 867.46M | 776.84M | 674.37M | 601.46M | 550.55M | 504.68M | 449.43M | 386.15M | 381.02M | 352.45M | 311.85M | 269.38M | 227.98M | 168.89M | 120.98M | 110.08M | 117.73M | 115.40M | 106.40M | 74.60M | 48.80M | 21.00M | 0.00 |
| Interest Income | 9.64M | 3.79M | 2.52M | 2.54M | 4.71M | 4.43M | 2.19M | 1.48M | 1.12M | 500.00K | 464.00K | 247.00K | 191.00K | 167.00K | 82.00K | 249.00K | 0.00 | 0.00 | 0.00 | 572.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 262.00K | 192.00K | 57.00K | 507.00K | 66.00K | 36.00K | 46.00K | 444.00K | 15.00K | 129.00K | 1.00K | 20.00K | 9.00K | 94.00K | 609.00K | 792.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 20.40M | 21.41M | 22.19M | 22.51M | 22.79M | 16.73M | 15.96M | 13.48M | 9.98M | 8.81M | 9.04M | 8.83M | 8.47M | 7.92M | 7.07M | 6.70M | 5.33M | 5.56M | 5.90M | 4.84M | 3.88M | 4.14M | 4.12M | 4.19M | 4.50M | 3.40M | 2.20M | 800.00K | 300.00K | 0.00 |
| EBITDA | 123.11M | 130.22M | 192.89M | 200.96M | 146.19M | 188.35M | 132.50M | 152.10M | 151.64M | 124.91M | 125.76M | 107.27M | 85.96M | 76.87M | 58.66M | 53.81M | 76.03M | 69.43M | 64.77M | 49.92M | 31.12M | 12.79M | 4.20M | 5.46M | 18.50M | 18.60M | 12.80M | 8.70M | 3.80M | 7.30M |
| EBITDA Ratio | 13.37% | 10.78% | 14.34% | 15.55% | 13.78% | 15.84% | 12.65% | 13.78% | 15.42% | 14.69% | 16.25% | 15.13% | 13.24% | 13.05% | 11.58% | 13.01% | 17.80% | 17.92% | 19.63% | 18.34% | 17.44% | 12.65% | 7.30% | 7.52% | 17.70% | 15.13% | 14.79% | 14.81% | 14.69% | 100.00% |
| Operating Income | 93.07M | 107.61M | 170.19M | 176.49M | 146.19M | 188.35M | 132.50M | 138.62M | 141.66M | 116.10M | 116.71M | 98.18M | 77.26M | 68.22M | 50.79M | 48.00M | 70.70M | 62.34M | 58.36M | 44.85M | 31.12M | 12.79M | 4.20M | 5.46M | 14.00M | 15.20M | 10.60M | 7.90M | 3.50M | 7.30M |
| Operating Income Ratio | 10.11% | 10.78% | 14.34% | 15.55% | 13.78% | 15.84% | 12.65% | 13.78% | 15.42% | 14.69% | 16.25% | 15.13% | 13.28% | 13.18% | 11.62% | 11.19% | 16.71% | 16.66% | 17.81% | 16.44% | 15.56% | 9.56% | 3.68% | 4.43% | 10.82% | 12.50% | 12.44% | 13.93% | 14.29% | 100.00% |
| Total Other Income/Expenses | 9.38M | 1.01M | 450.00K | 1.46M | 4.31M | 3.16M | 2.14M | -70.00K | 927.00K | -449.00K | -131.00K | 247.00K | 222.00K | 648.00K | 187.00K | -1.68M | 471.00K | 1.41M | 487.00K | 233.00K | 192.00K | -221.00K | -692.00K | -677.00K | -4.45M | 200.00K | 100.00K | 200.00K | 200.00K | -7.30M |
| Income Before Tax | 102.45M | 108.62M | 170.64M | 177.95M | 150.50M | 191.51M | 134.64M | 138.55M | 142.59M | 115.65M | 116.58M | 98.43M | 77.48M | 68.86M | 50.98M | 46.32M | 71.17M | 63.75M | 58.85M | 45.08M | 31.31M | 12.57M | 3.51M | 4.78M | 9.60M | 15.40M | 10.70M | 8.10M | 3.70M | 0.00 |
| Income Before Tax Ratio | 11.12% | 10.88% | 14.38% | 15.68% | 14.19% | 16.10% | 12.86% | 13.77% | 15.52% | 14.63% | 16.23% | 15.17% | 13.31% | 13.30% | 11.67% | 10.80% | 16.82% | 17.04% | 17.96% | 16.52% | 15.65% | 9.40% | 3.07% | 3.88% | 7.42% | 12.66% | 12.56% | 14.29% | 15.10% | 0.00% |
| Income Tax Expense | 38.67M | 39.27M | 54.14M | 53.28M | 49.97M | 65.29M | 72.11M | 38.51M | 47.92M | 39.02M | 37.56M | 31.99M | 26.73M | 23.21M | 17.42M | 16.38M | 25.24M | 22.49M | 19.86M | 14.30M | 10.49M | 4.07M | 1.31M | 1.91M | 3.70M | 5.90M | 4.10M | 3.10M | 1.40M | -300.00K |
| Net Income | 63.79M | 69.35M | 116.51M | 124.66M | 100.53M | 126.22M | 62.54M | 100.04M | 94.67M | 76.64M | 79.02M | 66.43M | 50.75M | 45.65M | 33.56M | 29.95M | 45.32M | 41.27M | 38.99M | 30.78M | 20.82M | 8.50M | 2.20M | 2.87M | 5.90M | 9.50M | 6.60M | 5.00M | 2.30M | 300.00K |
| Net Income Ratio | 6.93% | 6.94% | 9.82% | 10.99% | 9.48% | 10.61% | 5.97% | 9.94% | 10.31% | 9.69% | 11.00% | 10.24% | 8.72% | 8.82% | 7.68% | 6.98% | 10.71% | 11.03% | 11.90% | 11.28% | 10.41% | 6.36% | 1.92% | 2.33% | 4.56% | 7.81% | 7.75% | 8.82% | 9.39% | 4.11% |
| EPS | 3.31 | 3.60 | 5.78 | 5.89 | 4.44 | 5.36 | 2.60 | 4.09 | 3.71 | 3.11 | 2.85 | 2.40 | 1.70 | 1.43 | 1.10 | 0.94 | 1.36 | 1.15 | 1.03 | 0.81 | 0.55 | 0.23 | 0.06 | 0.07 | 0.12 | 0.18 | 0.13 | 0.10 | 0.05 | 0.01 |
| EPS Diluted | 3.30 | 3.59 | 5.73 | 5.86 | 4.41 | 5.12 | 2.53 | 3.99 | 3.59 | 2.80 | 2.78 | 2.23 | 1.63 | 1.43 | 1.09 | 0.93 | 1.32 | 1.10 | 0.99 | 0.76 | 0.49 | 0.21 | 0.06 | 0.07 | 0.12 | 0.17 | 0.12 | 0.10 | 0.05 | 0.01 |
| Weighted Avg Shares Out | 19.25M | 19.25M | 20.15M | 21.16M | 22.64M | 23.57M | 24.02M | 24.49M | 24.98M | 25.27M | 27.77M | 27.64M | 29.88M | 30.62M | 30.70M | 32.10M | 33.47M | 36.11M | 37.75M | 38.33M | 38.04M | 37.77M | 38.71M | 39.15M | 48.63M | 51.75M | 50.96M | 50.00M | 43.81M | 40.00M |
| Weighted Avg Shares Out (Dil) | 19.35M | 19.31M | 20.34M | 21.26M | 22.82M | 24.64M | 24.71M | 25.05M | 26.35M | 27.38M | 28.41M | 29.85M | 31.15M | 31.88M | 30.86M | 32.33M | 34.41M | 37.45M | 39.44M | 40.83M | 42.64M | 41.29M | 38.82M | 39.56M | 49.89M | 55.72M | 53.28M | 52.63M | 46.00M | 40.00M |
USANA Executive Chairman Kevin Guest Encourages Connections with July's "Social Wellness Month"
SALT LAKE CITY , July 1, 2024 /PRNewswire/ -- Throughout July, Kevin Guest, executive chairman at USANA Health Sciences (NYSE:USNA), is emphasizing boosting social connections during "Social Wellness Month." Social wellness—the ability to form meaningful relationships and interact positively with...
USNA or ZTS: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunity right now?
USANA Athlete Natalie Spooner Wins Inaugural PWHL MVP Award
PWHL Toronto forward also led the league in goals SALT LAKE CITY , June 18, 2024 /PRNewswire/ -- USANA would like to congratulate one of their sponsored athletes, Natalie Spooner on her Most Valuable Player award from the Professional Women's...
USNA vs. ZTS: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunity right now?
USANA Executive Chairman Kevin Guest Encourages Self-Renewal with June's "Rebuild Your Life Month"
SALT LAKE CITY , June 3, 2024 /PRNewswire/ -- For the month of June, Kevin Guest, executive chairman at USANA Health Sciences (NYSE:USNA), is emphasizing the significance of "Rebuild Your Life" month as an opportunity for individuals to take proactive...
USANA Partners with Cherries to Support Local Youth
AFC Bournemouth and USANA join forces to empower local youngsters with breakfast club initiatives SALT LAKE CITY , May 30, 2024 /PRNewswire/ -- USANA Health Sciences and its USANA Foundation have teamed up with English soccer club AFC Bournemouth to...
USANA Celavive Postbiotic Barrier Balm Named to Best in Skincare List
Barrier Balm awarded by BELLA Magazine SALT LAKE CITY , May 23, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in global nutrition, is proud to announce its Celavive Postbiotic Barrier Balm was recently named on BELLA magazine's 2024 Best...
USANA HR Executive Awarded for Excellence in his Field
Mike Sessions honored by Utah Business Magazine SALT LAKE CITY , May 15, 2024 /PRNewswire/ -- As a global leader in its industry, it's vital for a company like USANA to maintain a strong human resources department to ensure employees...
USANA Executive Chairman Kevin Guest Advocates for Family Wellness in May's Celebratory Month
SALT LAKE CITY , May 3, 2024 /PRNewswire/ -- In a heartfelt message in the heart of spring, Kevin Guest, executive chairman at USANA Health Sciences (NYSE:USNA), shares his insights and support for May's Family Wellness Month, an initiative that highlights...
USNA or STVN: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two companies is the best option for those looking for undervalued stocks?
Source: https://incomestatements.info
Category: Stock Reports